Online: 3007-3030
Print: 3007-3022
There is no publication fee applied on manuscript processing, submission and/or publication
The material submitted for publication may be in the form of an Original research (Randomized controlled trial - RCT, Meta-analysis of RCT, Quasi experimental study, Case Control study, Cohort study, Observational Study with statistical support, etc.), a Systematic Review Article, Commentary, a Case Report, Recent Advances, New Techniques, Debates, Adverse Drug Reports, Current Practices, Clinical Practice Article, Short Article, An Audit Report, Evidence Based Report, Short Communication or a Letter to the Editor.
should normally report original research of relevance to clinical medicine. A manuscript will be considered in the original article category if it is a Randomized Controlled Trial (RCT) or an Observational Study. RCT should be registered with International
ISRCTN Registry (Trial Registration Number mandatory). https://classic.clinicaltrials.gov/ Moreover, Retrospective Studies with adequate sample size supported by appropriate advance statistical analysis may also be considered in this category. Cross-sectional studies must follow the STROBE GUIDELINES Authors should clearly state in the manuscript under separate heading the name of the approval committee, highlighting that legal and ethical approvals were obtained prior to initiation of the research work carried out on subject, and that the experiments were performed in accordance with the relevant guidelines and regulation. Also, it is mandatory to provide the institutional ethical review board/committee approval for all research articles, at the time of submission of article. Dissertation/ thesis approval letter from relevant authority is also acceptable. The original paper should be of about 2000-2500 words excluding abstract and references.
It should contain a structured abstract of minimum 200 not exceeding 250 words. 3 to 10 keywords should be given for an original article as per MeSH (Medical Subject Headings) https://www.ncbi.nlm.nih.gov/mesh/ . There should be no more than three tables or illustrations. The data should be supported with 25 to 30 references, which should include local as well as international references. More than 50% of the references should be from last five years from the date of submission.
These articles are a category under which all simple observational case series are entertained. A manuscript will be considered in this category if it is a Descriptive Case Series or a Retrospective Study. The length of such article should be around 1500 - 1600 words with 15 - 20 references. The rest of the format should be that of an original article.
It must have at least 10 cases and word count of 1000 - 1200 words with 10 - 12 references and not more than 2 tables or illustrations. It should contain a non-structured abstract of about 150
words.
It should be of about 1000 - 1200 words, having a non-structured abstract of about 150 words with two tables or illustrations and not more than 6 references.
It must be of academic and educational value and provide relevance of the disease being reported as unusual. Brief or negative research findings may appear in this section. The word count of case report should be 800 words with a minimum of 3 key words. It should have a non-structured abstract of about 100 - 150 words (case specific) with maximum of 5 - 6 references. Not more than 2 figures and one table shall be accepted.
It Should consist of critical overview/analysis of some relatively narrow topic providing background and the recent development with the reference of original literature. It should incorporate author's original work on the same subject. The length of the review article should be of 2500 to 3000 words. It should have non-structured abstract of 150 words with minimum 3 key words.. Prisma Guideline should be considered http://prisma-statement.org/ .
It should normally not exceed 400 words, with not more than 5 references and be signed by all the authors-maximum 3 are allowed. Preference is given to those that take up points made in contributions published recently in the journal. Letters may be published with a response from the author of the article being discussed. Discussions beyond the initial letter and response will not be entertained for publication. Letters to the editor may be sent for peer review if they report a scientific data. Editorials are written upon invitation. Audit Reports, Current Practices, Survey Reports and Short Articles should be written in the format of Clinical Practice Article.
An article, based on dissertation, approved by institutional research unit, which was submitted as part of the requirement for a post-graduate program, can be sent for publication. However, provided the data is not more than three years old. A copy of approval letters of synopsis and dissertation obtained must be submitted with the research paper. Approval of synopsis from corresponding institute’s research unit is mandatory.
Dissertation based article should be re-written in accordance with the journal's instructions to the author guidelines. Article shall undergo routine editorial processing including external peer-review based upon which final decision shall be made for publication. Such articles, if approved, shall be published under the disclosure by author that 'it is a Dissertation based article'.
Abstract of an original article should be in structured format with the following subheadings:
The total word count of abstract should not be more than 250 words. A minimum of 3 to 5 key words as per MeSH (Medical Subject Headings) should be written at the end of abstract. A non-structured abstract should be written as case specific statement for case reports with a minimum of three key words.
This section should include the purpose of the article after giving brief literature review strictly related to objective of the study. The rationale for the study or observation should be summarized. Only strictly pertinent references should be cited and the subject should not be extensively reviewed. It is preferable not to cite more than 10 references in this segment. Data, methodology or conclusion from the work being reported should not be presented in this section. It should end with a statement of the study rationale and objective.
Study design, study setting, study population, inclusion/exclusion criteria, and sampling techniques and size should be mentioned. Obsolete terms such as retrospective studies should not be used. The selection of the observational or experimental subjects (patients or experimental animals, including controls) should be described clearly. and procedures be described in sufficient detail to allow other workers to reproduce the results. References to established methods should be given, including statistical methods. References and brief descriptions for methods that have been published but are not well-known should be provided; only new or substantially modified methods should be described in detail, giving reasons for using them, and evaluating their limitations. All drugs and chemicals used should be identified precisely, including generic name(s), dose(s), and route(s) of administration.
Ethical considerations and adherence to ethical guidelines should be mentioned along with IRB unique reference number obtained from the institute and ISCRTN number in case of RCT studies. Publication demanding any other approvals their unique ref number with corresponding institute should be mentioned here
For statistical analysis, the specific test used should be named, preferably with reference for an uncommon test. Exact p-values and 95% confidence interval (CI) limits must be mentioned instead of only stating greater or less than level of significance. All percentages must be accompanied with actual numbers. SPSS output sheet must be attached with manuscript to clarify results (p-values).
These should be presented in a logical sequence in the text, tables, and illustrations. All the data in the tables or illustrations should not be repeated in the text; only important observations should be emphasized or summarized with due statement of demographic details. No opinion should be given in this part of the text. Statistics should be given in an ascending or descendnig order
This section should include author's comment on the results, supported with contemporary references, including arguments and analysis of identical work done by other workers. Study limitations should also be mentioned. A summary is not required
Conclusion should be provided under separate heading and highlight new aspects arising from the study. It should be in accordance with the objectives. No recommendations are needed under this heading.
Any conflict of interest should be declared by all authors. This may include grants or honorarium, credits and promotions, memberships or any personal or professional relationships which may appear to influence the manuscript. Such competing interests are not unethical
but should be declared. If there are no conflict of interests, authors should still include this
heading and write "none to declare." or "Authors declared no conflict of interest".
Nonmonetary disclosures regarding being part of a thesis or dissertation, a pilot project or an ongoing study should be made explicitly at the time of submission
Any company or institution who has financially contributed to the study must be acknowledged.
Authors must state that the consent of the patient/guardian was taken prior to the writing of the manuscript if applicable
We accept the following file formats for figures:
Except for units of measurement, abbreviations are discouraged. The first time an abbreviation appears it should be preceded by the words for which it stands, However, the title and abstract must not contain any abbreviations.
Brand names of drugs are not permitted. Only generic names of drugs should be used.
Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. AI and AI-assisted technologies should not be listed as an author or co-author, or be cited as an author. Authorship implies responsibilities and tasks that can only be attributed to and performed by humans, as outlined in Elsevier’s AI policy for authors.
A submitted manuscript must be treated as a confidential document. Editors should not upload a submitted manuscript or any part of it into a generative AI tool as this may violate the authors’ confidentiality and proprietary rights and, where the paper contains personally identifiable information, may breach data privacy rights.
This confidentiality requirement extends to all communication about the manuscript including any notification or decision letters as they may contain confidential information about the manuscript and/or the authors. For this reason, editors should not upload their letters into an AI tool, even if it is just for the purpose of improving language and readability.
Online: 3007-3030
Print: 3007-3022
This is an open-access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
The open-access articles by International Annals of Health Sciences - Liaquat College of Medicine & Dentistry are licensed under Creative Commons Attribution-Non-Commercial 4.0 International.
Contact Us
International Annals of Health Sciences
Address: St-19, Johar Chowrangi Rd, KDA Scheme, Abul Asar Hafeez Jalandhari Rd, Block 15 Gulistan-e-Johar, Karachi, Karachi City, Sindh 75290
Email: editor.iahs@lcmd.edu.pk
Email: editor.iahs@gmail.com
Phone: 111-300-999, ext 219